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Following an acute central nervous system (CNS) injury, axonal regeneration and functional
recovery are extremely limited. This is due to an extrinsic inhibitory growth environment
and the lack of intrinsic growth competence. Retinoic acid (RA) signaling, essential in
developmental dorsoventral patterning and specification of spinal motor neurons, has been
shown through its receptor, the transcription factor RA receptor β2 (RARβ2), to induce
axonal regeneration following spinal cord injury (SCI). Recently, it has been shown that
in dorsal root ganglion neurons (DRGs), cAMP levels were greatly increased by lentiviral
RARβ2 expression and contributed to neurite outgrowth. Moreover, RARβ agonists, in
cerebellar granule neurons (CGN) and in the brain in vivo, induced phosphoinositide
3-kinase dependent phosphorylation of AKT that was involved in RARβ-dependent neurite
outgrowth. More recently, RA-RARβ pathways were shown to directly transcriptionally
repress a member of the inhibitory Nogo receptor (NgR) complex, Lingo-1, under an
axonal growth inhibitory environment in vitro as well as following spinal injury in vivo.
This perspective focuses on these newly discovered molecular mechanisms and future
directions in the field.
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INTRODUCTION
The limited regenerative capacity observed following an acute
central nervous system (CNS) lesion, such as stroke or
brain/spinal cord traumatic injuries, is due to both the presence
of an extrinsic inhibitory growth environment and the lack of
intrinsic growth factors. Interestingly, the peripheral nervous sys-
tem (PNS) does regenerate to a certain extent following a lesion,
which has led to further research to determine the distinction
between the CNS and PNS. The inhibitory environment of the
CNS is vastly different than that of the PNS (Richardson et al.,
1980). Following PNS injury, an inflammatory response is acti-
vated, Schwann cells infiltrate the injured area, debris is removed,
neurotrophic factors are released, regeneration is initiated, and
sheathing of these growing axons occurs (George and Griffin,
1994). Conversely, the glia cells in the CNS, oligodendrocytes,
and astrocytes, provide an inhibitory environment for growth
(McKeon et al., 1991; Qiu et al., 2000; Domeniconi et al., 2002;
Niederost et al., 2002; Yiu and He, 2006).
Specifically, the neuronal insulating layer, myelin, is frag-
mented following a CNS lesion, releasing the extrinsic inhibitory
molecules, myelin associated glycoprotein (MAG), Nogo, and
Oligodendrocyte myelin glycoprotein (OMgp) (DeBellard et al.,
1996; Huber and Schwab, 2000; Wang et al., 2002; He et al., 2003)
that inhibit axonal outgrowth and functional recovery follow-
ing injury. These myelin proteins signal through the neuronal
membrane boundNogo Receptor (NgR) complex, which includes
NgR1 (Chen et al., 2000; GrandPre et al., 2000), Lingo-1 (Mi et al.,
2004), and p75NTR (Domeniconi et al., 2002; Wong et al., 2002)
or TROY (Park et al., 2005). Myelin protein engagement of the
NgR complex activates RhoA, which induces ROCK-dependent
phosphorylation of cofilin, thus actin depolymerization and
growth cone collapse (He and Koprivica, 2004). When the RhoA
pathway has been blocked following a CNS lesion, regeneration
has been observed (Lehmann et al., 1999; Dergham et al., 2002;
Fournier et al., 2003). The Paired immunoglobulin-like recep-
tor B (PirB) is another receptor with high affinity for myelin
inhibitory molecules that mediates outgrowth inhibition through
dephosphorylation of tropomyosin receptor kinase (Trk) neu-
rotrophin receptors (Atwal et al., 2008; Fujita et al., 2011).
Although following a severe CNS lesion a glial scar forms to
repair the site of blood brain barrier disruption and limit inflam-
mation (Rolls et al., 2009) it also represents a physical barrier to
axonal growth (McKeon et al., 1991). The glial scar consistsmainly
of reactive astrocytes proteoglycans, and collagen, of which colla-
gen IV provides the basement membrane scaffold for chondroitin
sulphate proteoglycans (CSPGs) to bind (McKeon et al., 1991).
It has been shown that CSPGs, of the glial scar, are inhibitory to
axonal outgrowth in culture via binding to the recently discovered
receptor PTPsigma (McKeon et al., 1991; Snow et al., 1996; Shen
et al., 2009). Furthermore, removing CSPG glycosaminoglycan
chains with chondroitinase ABC (ChABC) promotes functional
recovery after spinal cord injury (SCI) (Bradbury et al., 2002).
More recently, the axonal regeneration field has par-
tially shifted to elucidating the intrinsic growth capacity of
CNS neurons. Not surprisingly, many well-defined embryonic
developmental pathways have become validated in adult stem
cell proliferation, regeneration, and differentiation (Tsokos et al.,
1987; Terenghi, 1999; Esposito et al., 2005; Harel and Strittmatter,
2006; Reimer et al., 2009). This supports the theory that regener-
ation can be accomplished by a revival of developmental signals.
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It is believed that CNS neurons possess the ability, albeit lim-
ited, to regenerate. For example, the growth of CNS neurons
into a PNS environment is possible (David and Aguayo, 1981;
Benfey and Aguayo, 1982). It has been shown that the elongation
of axons is linked to de novo transcription, and that block-
ing transcription immediately after injury inhibits regeneration
from occurring (Smith and Skene, 1997). Furthermore, regener-
ation associated genes (RAGs) have been found following PNS
injury that are absent following CNS injury in adults (Makwana
and Raivich, 2005). These include GAP-43 and CAP-23 (growth
cone proteins) (Chong et al., 1994; Mason et al., 2002), Sprr1a
and SCG-10 (cytoskeletal proteins) (Mason et al., 2002; Starkey
et al., 2009), Galanin (neuropeptide) (Holmes et al., 2000), brain
derived neurotrophic factor (BDNF) (Tonra et al., 1998), as well
as Chl1 and Lgals1 (cell adhesion molecules) (Zhang et al., 2000),
and galectin-1 (McGraw et al., 2004). Furthermore, following
a conditioning lesion, upregulation of cAMP activates protein
kinase A (PKA), which in turn phosphorylates the transcription
factor cAMP response element-binding protein (CREB), induc-
ing transcription thus leading to neurite outgrowth (Neumann
et al., 2002; Qiu et al., 2002; Gao et al., 2004). Interestingly,
it has been shown that when neurons mature they lose their
ability to overcome an inhibitory environment and this transi-
tion coincides with a decrease in cAMP levels (Cai et al., 2002).
Another transcription factor thought to be involved in the retro-
grade signal following a conditioning lesion is signal transducer
and activator of transcription 3 (STAT3) (Bareyre et al., 2011),
which is activated via phosphorylation by tyrosine kinase Janus
kinase (JAKs) associated with the receptor subunit glycoprotein
130 (gp130) initiated by the growth factor ciliary neurotrophic
factor (CNTF) (Schwaiger et al., 2000). When either CREB or
STAT3 pathways are blocked, regeneration in the CNS following
a conditioning lesion is abolished (Gao et al., 2004; Qiu et al.,
2005). Furthermore, it has also been shown in vitro that the
conditioning lesion effect is completely abolished in a gp130 con-
ditional knockout (Hyatt Sachs et al., 2010). However, Il-6 has
been shown to be sufficient but not necessary for conditioning
lesion-dependent axonal regeneration (Cao et al., 2006).
A number of injury responsive transcription factors have also
been shown to affect neurite outgrowth and axonal regenera-
tion, such as p53, c-Jun, activating transcription factor 3 (ATF3),
nuclear factor of activated T cells (NFATs), nuclear factor kappa-
light-chain-enhancer of activated B cells (NFκB), SRY-box con-
taining gene 11 (Sox11), SnoN, and the Krüppel-like factor (KLF)
family (reviewed in (Moore and Goldberg, 2011).
In addition to gene regulation it has been recently discovered
that signaling pathways involving protein translation can induce
axonal regeneration both in the PNS and CNS (Park et al., 2008;
Christie et al., 2010; Liu et al., 2010). Classically known as a tumor
suppressor, phosphatase and tensin homolog (PTEN), has been
shown to counteract phosphoinositide 3-kinases’ (PI3K) con-
version of the lipid second messenger phosphatidylinositol (4,5)
bisphosphate (PIP2) into phosphatidylinositol (3,4,5) triphos-
phate (PIP3) (Song et al., 2005). When PTEN is inhibited or
deleted, there is an increase in activation of AKT by phosphory-
lation (Song et al., 2005). This in turn has led to an increase in
axonal regeneration, which has been determined to be through
the downstream activation of the mTOR leading to protein syn-
thesis and cell growth (Guertin and Sabatini, 2007; Park et al.,
2008; Christie et al., 2010; Liu et al., 2010).
RETINOIC ACID SIGNALING PATHWAYS IN AXONAL
REGENERATION
Retinoic acid (RA), a degradation product of retinol after food
ingestion, is a lipophilic vitamin A derivative that readily trans-
verses the blood-brain barrier (Le Doze et al., 2000), and is a
ligand for several nuclear receptors such as RA receptors (RAR,
α, β, or γ, each of which have several isoforms due to alterna-
tive splicing) that play a role as transcription factors (Chambon,
1996). RA signaling is dependent upon its nuclear availability,
controlled among others by retinol-binding protein-1 (RBP1),
which is the carrier protein involved in the transport of retinol
from the liver storage site to peripheral tissue and by cellular
retinol binding protein (CRBP), which is the intracellular car-
rier involved in intracellular movement of retinol (Le Doze et al.,
2000). Interestingly, the administration of RA not only activates
the transcription factor RARβ by direct binding that releases co-
repressors from promoters and recruits co-activators, but also
increases its gene expression (Sucov et al., 1990; Leid et al., 1992).
Importantly, a cAMP response element was found on RARβ2
promoter, which binds CREB in response to cAMP and induces
RARβ2 expression (Kruyt et al., 1992). In the presence of ligand,
RA bound RARβ typically forms a heterodimer with retinoid X
receptor (RXR, α, β, or γ) at RA response elements (RAREs) in
gene promoters, recruits co-activators (CBP/p300, the CBP/p300
associated factor PCAF, SRC1, p160 pCIP, CoA, SWI/SNF, and
ACTR) and activates transcription (Chambon, 1996; Glass and
Rosenfeld, 2000). However, in the absence of ligand, RARβ binds
DNA in concert with co-repressors (nCo-R, SMRT, HDAC, and
mSin3) and inhibits transcription (Glass and Rosenfeld, 2000).
There have been several documented cases where RA bound
RARβ was found to occupy promoters independently from RXR
and to repress transcription (Glass et al., 1989; Lipkin et al.,
1992; Schoorlemmer et al., 1994). RA signaling typically involves
direct transcriptional regulation, even though there are some
less-defined cases involving non-transcriptional dependent RA
signaling (Lopez-Carballo et al., 2002; Masia et al., 2007; Ohashi
et al., 2009).
RA SIGNALING IN NEURITE OUTGROWTH AND AXONAL
REGENERATION
Classically involved in development, neuronal differentiation,
ventral neural patterning, and motor neuron specification
(Maden et al., 1996; Diez del Corral et al., 2003; Novitch
et al., 2003; Sockanathan et al., 2003), more recently RA also
became a prime candidate to induce neurite outgrowth in neu-
rons. The addition of exogenous RA and/or RARβ2 has been
shown to induce neurite outgrowth in vitro in dorsal root
ganglion neurons (DRGs), adult cortical neurons, and postna-
tal cerebellar granule neurons (CGN) (Corcoran and Maden,
1999; Corcoran et al., 2000; Wong et al., 2006; Yip et al., 2006;
Puttagunta et al., 2011). In embryonic and adult DRGs as well
as CGN, RA upregulated the expression RARβ2 in correlation
with induced neurite outgrowth (Corcoran and Maden, 1999;
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Corcoran et al., 2000; Puttagunta et al., 2011). Neurotrophins,
such as nerve growth factor (NGF), essential in the development
of the PNS (Piirsoo et al., 2010), have been shown to upregulate
retinaldehyde dehydrogenase-2 (RALDH-2) and RARβ2 expres-
sion to induce neurite outgrowth of adultmouseDRGs (Corcoran
and Maden, 1999). Moreover, a RARβ agonist, but not a RARα
or RARγ agonist, induced neurite outgrowth from embryonic
DRGs (Corcoran et al., 2000). Additionally, both cortex and DRG
explants from adult rats treated for 14 days with a RARβ agonist
induced neurite outgrowth in contrast to vehicle treated animals
(Agudo et al., 2010). As a proof of principle that RA mediates
its effect on neurite outgrowth exclusively through RARβ, it was
shown in postnatal CGN that RARβ null CGN fail to extend
neurites in response to RA (Puttagunta et al., 2011). Whereas,
embryonic spinal cord explants respond to RA by inducing neu-
rite outgrowth, adult spinal cord explants do not, and the lim-
ited RARβ2 expression in the adult spinal cord in comparison
to the embryonic spinal cord is believed to be the reason for
this difference (McCaffery and Drager, 1994; Zetterstrom et al.,
1999; Corcoran et al., 2002; So et al., 2006; Yip et al., 2006).
Furthermore, when RARβ2, yet not RARβ4, was virally intro-
duced into the adult spinal cord in organotypic preparations, it
induced neurite outgrowth (Corcoran et al., 2002). Therefore,
it can be concluded that RA acts specifically through RARβ2
in inducing neurite outgrowth in both embryonic and adult
neurons.
Having established RARβ2 as the receptor responsible for RA
induction of neurite outgrowth, the next logical step was to show
that overexpression of RARβ2 in vivo would induce axonal regen-
eration. RARβ2 lentiviral infection of adult rat DRGs induced
axonal growth and functional recovery of injured sensory neu-
rons into the dorsal root entry zone (DREZ) following dorsal root
lesion (Wong et al., 2006). In support of these findings, it was also
shown that RARβ2 null mice have less axonal regeneration follow-
ing a peripheral nerve crush versus wildtype mice (So et al., 2006).
Additionally, RARβ2 lentiviral infection of the sensorimotor cor-
tex three weeks prior to spinal cord lesion induced axonal and
functional regeneration of the cortical spinal tracts (CST) in adult
rats (Yip et al., 2006). Finally, RARβ specific agonist, CD2019,
brain treated rats following a dorsal column lesion had increased
growth of CST axons and functional recovery of the forelimb ver-
sus those administered with vehicle (Agudo et al., 2010). These
in vivo studies confirmed previous in vitro studies, showing that
indeed RA-RARβ signaling is involved in neurite outgrowth and
axonal regeneration.
THE MOLECULAR MECHANISMS OF RA SIGNALING IN AXONAL
REGENERATION
While it is known that RA signaling does induce neurite out-
growth and axonal regeneration only limited research has been
done on the precise molecular mechanisms involved. It was
shown that lentiviral RARβ2 expression induces neurite out-
growth in DRGs and increases cAMP levels (Wong et al.,
2006). The effect of RARβ2 on neurite outgrowth was sig-
nificantly decreased when an adenylate cyclase inhibitor, 2′,5′-
dideoxyadenosine (DDA) or a cell–permanent inhibitor of cAMP-
dependent PKA was used (Wong et al., 2006). While this suggests
that cAMP is involved in RA signaling, it is not sufficient, as use
of dibutyryl cAMP in adult DRGs in the DREZ model did not
promote functional recovery as robustly as RARβ2 alone (Wong
et al., 2006). In fact, it was shown in postnatal CGN that the pos-
itive affect of a RARβ agonist (CD2019) on neurite outgrowth
was fully attenuated by a PI3K inhibitor but not a PKA inhibitor.
Furthermore, it was shown that RARβ induced phosphorylation
of AKT in CGNand in vivo, exclusively in injured neurons (Agudo
et al., 2010). Interestingly, it has been previously shown that RA-
RARβ2/RXR directly activates AKT during the differentiation of
human neuroblastoma cells (Lopez-Carballo et al., 2002; Ohashi
et al., 2009).
Recently, we have discovered a direct transcriptional target of
RA signaling in neurite outgrowth in an inhibitory environment.
RA signaling increases neurite outgrowth, decreases RhoA activa-
tion and inhibits Lingo-1 gene and protein expression in amyelin-
inhibitory environment (however, not on a CSPG-inhibitory
substrate) in CGN, specifically through RARβ. By in silico analy-
sis, we discovered a RARE in the Lingo-1 promoter, which bound
RARβ but not RXR upon RA treatment in a myelin-inhibitory
environment. Moreover, we showed this RARE to be functional
by a luciferase assay that when mutated did not respond to RA
signaling. Furthermore, addition of Lingo-1 in RA-treated CGN
in a myelin-inhibitory environment abrogated RA-RARβ induced
neurite outgrowth. Finally, in vivo RA treatment decreased Lingo-
1 protein expression following SCI in wildtype but not in RARβ
null mice, providing physiological relevance to the in vitro find-
ings (Puttagunta et al., 2011) (Figure 1A). Importantly, it has
previously been shown that Lingo-1 antagonists promoted axonal
sprouting, improved functional recovery, decreased RhoA activa-
tion, and increased oligodendrocyte and neuronal survival fol-
lowing rubrospinal or CST transection (Ji et al., 2006). It will be
important to determine if this RA-dependent decrease in Lingo-1
is found exclusively in the neurons or also in the oligodendro-
cytes that make up the myelin sheathing and if RA signaling, such
as seen with Lingo-1 inhibtion (Mi et al., 2005, 2007, 2009), leads
to an increase in remyelination. In fact, for proper functionality
following SCI, axons must re-grow, reinnervate their targets, and
remyelinate their axons.
RA AND EPIGENETICS
Epigenetics changes can affect gene regulation by modifying the
surrounding chromatin environment. They include DNAmethy-
lation and a number of histone post-translational modifications
such as phosphorylation, acetylation, andmethylation. For exam-
ple, methylation of promoters or histones often inhibits gene
expression, yet acetylation of histones or transcription factors
induces gene expression by promoting transcription factor occu-
pancy within amore accessible chromatin environment (reviewed
in (Kouzarides, 2007; Mueller and von Deimling, 2009). These
epigenetic changes can be transient or more long lasting thereby
allowing extrinsic and intrinsic cellular signals to immediately
and strongly influence gene expression (Guasconi and Puri,
2009). The acetyltransferases, CBP/p300, are essential for mam-
malian cell proliferation and development (Yao et al., 1998).
Importantly, p300 appears to be a critical cofactor for RAR tran-
scriptional activity, even leading to differentiation and somitic
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FIGURE 1 | RA-RARβ dependent direct transcriptional repression of
inhibitory myelin signaling and a hypothetical schematic of RA
involvement in retrograde signaling, RAGs expression, and axonal
regeneration. (A) Following RA treatment HDAC3 binding to the RARE of
the Lingo-1 promoter decreases acetylation of H3 lysine 9 and possibly
displaces PCAF binding. Meanwhile, an increase in methylation of H3 lysine
27 is observed, coupled with strong binding of a RARβ homodimer to the
RARE of the Lingo-1 promoter repressing Lingo-1 expression. This is
believed to displace the equilibrium of the NogoR complex and block the
activation of RhoA, thus leading to neurite outgrowth. Other possible
members of this transcriptional repressor complex may include NCoR and
SMRT (indicated with dashed lines). (B) Following a conditioning peripheral
lesion and RA treatment an increase in RARβ, pCREB, and pSTAT3 levels
are observed. All three have been shown to be vital to PNS axonal
regeneration. CREB and STAT3 have been shown to play a role in
retrograde signaling involved in the induction of RAGs expression prior to
axonal regeneration. It will be intriguing to examine if RA signaling
activates these three transcription factors to work in concert regulating
RAGs expression to induce both axonal CNS and PNS regeneration
in vivo.
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symmetry (Kawasaki et al., 1998; Yao et al., 1998; Vilhais-Neto
et al., 2010). Furthermore, in spinal motor neuron develop-
ment, CBP is recruited by RA activated RAR to promoters for
acetylation of histones, increasing accessibility of the promoter
to transcription factors and inducing the expression of spinal
motor neuron genes (Lee et al., 2009). RA signaling initiates
PCAF binding to RAR/RXR heterodimers displacing co-repressor
complexes and inducing gene expression (Blanco et al., 1998).
Preliminary findings show (personal observations) that acety-
lation of histone 3 at lysine 9 (AcH3K9) at the RARE of the
Lingo-1 promoter is significantly decreased upon RA treatment
in a myelin-inhibitory environment. In accordance, we saw an
increase in histone deacetylase 3 (HDAC3, known to form a
repressor complex with NCoR/SMRT at RA regulated genes)
(Hartman et al., 2005) on the RARE of the Lingo-1 promoter.
In addition, we observed an increase in methylation on H3 at
lysine 27 (H3K27Me3, also known to be previously linked to
RA mediated differentiation) (Gillespie and Gudas, 2007). These
observations further extend upon recent published work showing
a decrease in Lingo-1 expression upon RA treatment in a myelin-
inhibitory environment (Puttagunta et al., 2011) (Figure 1A),
however, further examination is required to determine complete
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FIGURE 2 | RA-dependent non-transcriptional involvement in
neurite outgrowth. Inhibition of PTEN leads to increased levels of PIP3 via
PI3K. This in turn activates AKT by phosphorylation. Active pAKT has many
functions such as the inhibition of GSK-3, Bad, or Bax, conversely it can
activate Raf, RacI, and NF-κB. Recently in axonal regeneration it has been
shown that active pAKT leads to the activation of the mTOR pathway
(which can be inhibited via rapamycin). This leads to increased protein
synthesis and ribosome biogenesis as well as cell growth through the
phosphorylation of the ribosomal protein S6 and the release of the
eukaryotic initiation factor 4E (eIF-4E) from inhibition. RA-RARβ
signaling has shown an inhibition of PTEN and a direct activation of
pAKT in two separate studies. It will be of interest to examine if RA
signaling induces downstream mTOR signaling in axonal
regeneration.
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activator and repressor complexes involved in RA-dependent
Lingo-1 regulation.
FUTURE PERSPECTIVES
In order to achieve functional axonal regeneration and recov-
ery following SCI several obstacles need to be overcome: (a)
an inhibitory glial environment, (b) excessive inflammation, (c)
lack of neuronal intrinsic capacity for axonal outgrowth, and
(d) axonal demyelination. In fact, RA signaling seems to have the
potential to tackle several of these limitations.
RA has long been known for its anti-inflammatory benefits
(Orfanos and Bauer, 1983; Nozaki et al., 2006). Interestingly, RA
has been shown to inhibit the interferon-gamma induced inflam-
matory response in primary rat brain cultured astrocytes by
inducing suppressors of cytokine signaling (SOCS3) and inhibit-
ing JAK and STAT3 activation (Choi et al., 2005). Thus, it will
be of interest to elucidate weather RA treatment in vivo follow-
ing SCI reduces the formation of a glial scar by inhibiting the
inflammatory response.
As the RA-RARβ pathway seems to overcome the myelin
inhibitory environment, but not necessarily proteoglycan inhi-
bitory signaling, combining ChABC with enhancement of RA-
RARβ should strongly reduce the inhibitory signaling following
SCI and further promote axonal regeneration than either does
alone.
Given that neuronal overexpression of RARβ promotes axonal
sprouting and regeneration of the CST and dorsal columns after
SCI, it will be interesting to explore whether RA-RARβ is able
to enhance the intrinsic ability of CNS neurons to regenerate
by driving the expression of specific RAGs. Besides a possible
direct transcriptional role for RAGs, RA-RARβ signaling may be
involved in the cAMP-dependent retrograde signal following a
PNS lesion that induces RAGs expression (Qiu et al., 2002). In
fact, RARβ null mice have significantly reduced neurite outgrowth
following peripheral nerve crush compared to wildtype mice
(So et al., 2006), and, as mentioned previously, cAMP is induced
by RARβ overexpression and involved in its ability to induce neu-
rite outgrowth (Wong et al., 2006). Moreover, STAT3 is thought
to be a retrograde signal following a PNS lesion and its inhibition
limits axonal regeneration (Qiu et al., 2002, 2005; Schweizer et al.,
2002; Bareyre et al., 2011). While STAT3 is inhibited by RA signal-
ing in astrocytes, conversely it is induced in a CNTF-dependent
manner in differentiated neuroblatoma cells, retinal, and ciliary
chick ganglion neurons (Malek and Halvorsen, 1997; Wang and
Halvorsen, 1998). It will be of interest to inspect if RA-RARβ,
CREB, and STAT3 transcriptional signaling work in concert to
induce expression of RAGs and axonal regeneration (Figure 1B).
RA may also intersect with PTEN-mTOR signaling after SCI.
The inhibition of PTEN results in the activation of AKT (pAKT)
inducing axonal regeneration throughmTOR by new protein syn-
thesis and growth (Park et al., 2008). Accordingly, pAKT, which
decreases after axonal injury (Liu et al., 2010), was shown to be
only upregulated in injured CST axons following treatment with
a RARβ agonist (Agudo et al., 2010). Therefore, it will be inter-
esting to determine if AKT activation by RA signaling is through
the inhibition of PTEN or the direct phosphorylation of AKT
following axonal lesions and if this results in mTOR activation
(Figure 2). In fact, dissection of this pro-regenerative molecu-
lar pathway may offer novel molecular targets for the effective
enhancement of axonal regeneration.
Moreover, as RA signaling may take place via either paracrine
or autocrine pathways and as Schwann cells, astrocytes, meningeal
fibroblasts, and macrophages differentially express RA, RAR, or
RALDH2 after PNS and CNS injury (Mey, 2006), further investi-
gation of the relative weight of the two modes of action in axonal
regeneration is warranted.
While RA pathways seem to positively affect several pathogenic
aspects of SCI, further investigation is needed to clarify more
direct transcriptional targets of RA-RARβ signaling following SCI
and the interaction of RA pathways with other pro-regenerative
signals. Only then, may we have the possibility to design RA
signaling-dependent molecular therapies that may specifically
enhance spinal axonal regeneration and recovery, with limited off
target side effects.
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